Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemic by Tipton, TRW, White, A, Hall, Y, Gao, X, Yuki, Y, Martin, M, Ewer, K, Carrington, M, Carroll, MW

Enhancing the biological relevance of machine learning classifiers for reverse vaccinology by Heinson, A, Gunawardana, Y, Moesker, B, Hume, C, Vataga, E, Hall, Y, Stylianou, E, McShane, H, Williams, A, Niranjan, M, Woelk, C

Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea by Akoi Boré, J, Timothy, JWS, Tipton, T, Kekoura, I, Hall, Y, Hood, G, Longet, S, Fornace, K, Lucien, MS, Fehling, SK, Koivogui, BK, Coggins, SA, Laing, ED, Broder, CC, Magassouba, NF, Strecker, T, Rossman, J, Konde, K, Carroll, MW

Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model by Wing, PAC, Prange-Barczynska, M, Cross, A, Crotta, S, Orbegozo Rubio, C, Cheng, X, Harris, JM, Zhuang, X, Johnson, RL, Ryan, KA, Hall, Y, Carroll, MW, Issa, F, Balfe, P, Wack, A, Bishop, T, Salguero, FJ, McKeating, JA

Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model by Wing, PAC, Prange-Barczynska, M, Cross, A, Crotta, S, Orbegozo Rubio, C, Cheng, X, Harris, J, Zhuang, X, Johnson, R, Ryan, K, Hall, Y, Carroll, M, Issa, F, Balfe, P, Wack, A, Bishop, T, Salguero, F, McKeating, J

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’e... by Watson, CH, Gsell, P, Hall, Y, Camacho, A, Riveros, X, Enwere, G, Vicari, A, Nadlaou, SD, Toure, A, Sani, IM, Diallo, A, Kolie, C, Duraffour, S, Ifono, K, Maomou, A, Dore, K, Djidonou, HA, Bagayoko, A, Damey, PP, Camara, MN, Diallo, FB, Oumar, FT, Toure, K, Diaby, ML, Tipton, T, Carroll, MW

Influence of aerosol delivered BCG vaccination on immunological and disease parameters following SARS-CoV-2 challenge in rhesus macaques by White, AD, Sibley, L, Sarfas, C, Morrison, AL, Bewley, K, Churchward, C, Fotheringham, S, Gkolfinos, K, Gooch, K, Handley, A, Humphries, HE, Hunter, L, Kennard, C, Longet, S, Mabbutt, A, Moffatt, M, Rayner, E, Tipton, T, Watson, R, Hall, Y, Bodman-Smith, M, Gleeson, F, Dennis, M, Salguero, FJ, Carroll, M, McShane, H, Cookson, W, Hopkin, J, Sharpe, S

A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 by Huo, J, Mikolajek, H, Le Bas, A, Clark, JJ, Sharma, P, Kipar, A, Dormon, J, Norman, C, Weckener, M, Clare, DK, Harrison, PJ, Tree, JA, Buttigieg, KR, Salguero, FJ, Watson, R, Knott, D, Carnell, O, Ngabo, D, Elmore, MJ, Fotheringham, S, Harding, A, Moynié, L, Ward, PN, Dumoux, M, Prince, T, Hall, Y, Hiscox, JA, Owen, A, James, W, Carroll, MW, Stewart, JP, Naismith, JH, Owens, RJ

The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection by Goldswain, H, Dong, X, Penrice-Randal, R, Alruwaili, M, Shawli, GT, Prince, T, Williamson, MK, Raghwani, J, Randle, N, Jones, B, Donovan-Banfield, I, Salguero, FJ, Tree, JA, Hall, Y, Hartley, C, Erdmann, M, Bazire, J, Jearanaiwitayakul, T, Semple, MG, Openshaw, PJM, Baillie, JK, Emmett, SR, Digard, P, Matthews, DA, Turtle, L, Darby, AC, Davidson, AD, Carroll, MW, Hiscox, JA, Carson, G, Dunning, J, Horby, PW, Klenerman, P, Mentzer, AJ, Merson, L, Sigfrid, L, Stuart, D, Angus, B